Recombinant Chlamydia trachomatis serovar L2b Lipoyl synthase (lipA)

Gene target

Chlamydia trachomatis serovar L2b Lipoyl synthase lipA
Short name

Recombinant Chlamydia trachomatis serovar L2b Lipoyl synthase (lipA)
Technique

Recombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. MyBioSource advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
Species

Chlamydia, Chlamydias
Alternative name

Rec. Chlamydia trachomatis serovar L2b Lipoyl synthase (lipase A, lysosomal acid, cholesterol esterase)
Alternative technique

rec
Alternative to gene target

lipase A, lysosomal acid, cholesterol esterase, CESD and LAL, LIPA and IDBG-81838 and ENSG00000107798 and 101926887,3988, lipase activity, multiple, Lipa and IDBG-159667 and ENSMUSG00000024781 and 16889, BT.65903 and IDBG-637363 and ENSBTAG00000003636 and 100125267
Disease

chlamydia, Cervix, urethra an eye infection by Chlamydia trachomatis can form inclusion bodies in humans.

Name

Blood Grouping and Crossmatching
Concept

Scope note: Testing erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. Crossmatching is performed prior to transfusion.
Tree numbers
- E01.370.225.625.120
- E01.370.225.812.385.120
- E05.200.625.120
- E05.200.812.385.120
- E05.478.594.385.120
Qualifiers

ethics, mortality, psychology, trends, veterinary, history, classification, economics, instrumentation, methods, nursing, standards, adverse effects, statistics & numerical data